Which companies are Unichem Laboratories's closest peers?

The cockpit's peer set: Chongqing Hifuture Information Technology (002168.SZ), Anhui Fengyuan Pharmaceutical (000153.SZ), Avalo Therapeutics (AVTX), Shukra Pharmaceuticals (SHUKRAPHAR.NS), Rezolute (RZLT), Guizhou Yibai Pharmaceutical (600594.SS), Kingchem (Liaoning) Life Science (301509.SZ), Hinova Pharmaceuticals (688302.SS).

Is Unichem Laboratories expensive compared with its peers?

On ev / sales it trades at 1.5× against a peer median of 5.2×, 3rd cheapest of 16 in its peer set.

How has Unichem Laboratories stock performed?

Over six months to 6 Nov 2026 the shares returned +27.9% against -21.9% for the median peer; over one year +5.8%.

← CockpitCompetitor Analysis › UNICHEMLAB.NS Unichem Laboratories LimitedOpen in the cockpit ↗

Unichem Laboratories LimitedUNICHEMLAB.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Pharmaceuticals: Major

Momentum strong 76

Competitor Analysis ▸ Charts Open in the cockpit

Mkt cap

$373M

US dollars, full cap

Free float

28%

of shares outstanding

$/day

$334,297

20-day average traded

Fwd P/E

n/m

no positive forecast

ROIC−WACC

-11.5 pp

WACC 14.4%

Hurdle

n/a

no reverse DCF

Close · INR₹501.70

1D+1.7%

1W+3.7%

1M-8.2%

3M+0.9%

6M+27.9%

YTD+13.6%

1Y+5.8%

ATR %5.1%

Beta0.70

52w lowhigh27.0% off high

What Unichem Laboratories does

Employees: 2,815

Unichem Laboratories at a glance

Size Unichem Laboratories (UNICHEMLAB.NS) is an India Health Care company (Pharmaceuticals: Major) with a market value of $373M, the 967th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹501.70 on 6 Nov 2026.

Performance Over six months the shares gained 27.9%, against -21.9% for the median peer and 0.0% for the India market (cap-weighted) — 2nd highest of 19 in its peer set.

Growth Revenue grew 9.4% over the last twelve months (peer median +2.3%); the operating margin is 4.6% (peer median -13.4%).

Valuation It trades at 1.5× enterprise value to sales against a peer median of 5.2× (3rd cheapest of 16).

Capital Return on invested capital runs 11.5 points below its cost of capital (14.4% WACC).

Relative performance

Six months, rebased to 100: Unichem Laboratories against the median of its 20 peers (local-currency closes).

Unichem Laboratories financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
	TTM	FY2025	FY2024	FY2023	FY2022
Revenue	₹23.1B	₹21.8B	₹20.8B	₹17.5B	₹13.3B
Revenue growth	—	+5%	+19%	+32%	—
Gross profit	₹7.25B	₹4.80B	₹5.10B	₹3.15B	₹1.39B
EBITDA	₹2.29B	₹1.10B	₹2.34B	-₹765M	-₹594M
Net income	₹3.05B	₹2.53B	₹1.38B	-₹938M	-₹2.02B
Free cash flow	n/a	-₹1.39B	-₹1.62B	-₹302M	-₹1.45B
Capital expenditure	n/a	₹1.23B	₹1.37B	₹226M	₹443M
Total debt	n/a	₹5.00B	₹4.60B	₹2.48B	₹3.14B

Quarterly statements and history in the cockpit →

Unichem Laboratories competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

Up and to the right = strong over both horizons. Unichem Laboratories is the large dot.

Fundamentals: revenue growth against valuation

Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Unichem Laboratories is the large dot.

Unichem Laboratories competitors and peer comparison

How Unichem Laboratories compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Unichem Laboratories against its 20 peers (data as of 6 Nov 2026)
Measure	UNICHEMLAB.NS	Peer median	Rank in peer set
1-month return	-8.2%	-12.0%	8th highest of 20
6-month return	+27.9%	-21.9%	2nd highest of 19
Distance from 52-week high	-27.0%	-38.2%	5th highest of 21
Revenue growth (TTM)	+9.4%	+2.3%	6th highest of 18
Operating margin	4.6%	-13.4%	5th highest of 17
EV / Sales	1.5×	5.2×	3rd cheapest of 16
ROIC minus cost of capital	-11.5 pp	-8.8 pp	7th lowest of 16
EV / EBITDA	15.4×	26.8×	3rd cheapest of 5
Net debt / EBITDA	0.9×	0.5×	4th least indebted of 7

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
Company	Market	Market cap	6M return	Revenue growth	Op. margin	EV / Sales	Req g	Delivered g
Unichem Laboratories UNICHEMLAB.NS	India	$373M	+28%	+9%	5%	1.5×	n/a	n/a
Chongqing Hifuture Information Technology 002168.SZ	China	$372M	-23%	+2%	-6%	8.3×	16.3%	-14.0%
Anhui Fengyuan Pharmaceutical 000153.SZ	China	$372M	-17%	-24%	3%	1.1×	4.2%	+3.1%
Avalo Therapeutics AVTX	United States	$372M	-68%	-87%	-154,844%	n/a	n/a	n/a
Shukra Pharmaceuticals SHUKRAPHAR.NS	India	$372M	n/a	+115%	57%	46.9×	n/a	n/a
Rezolute RZLT	United States	$375M	+21%	n/a	n/a	n/a	n/a	n/a
Guizhou Yibai Pharmaceutical 600594.SS	China	$376M	-21%	-26%	-15%	2.0×	9.0%	-11.3%
Kingchem (Liaoning) Life Science 301509.SZ	China	$368M	-25%	+3%	6%	1.8×	13.2%	+6.5%
Hinova Pharmaceuticals 688302.SS	China	$366M	-24%	+251%	-195%	22.0×	n/a	n/a
TRex Bio TRXB	United States	$364M	n/a	-100%	n/a	n/a	n/a	n/a
JCR Pharmaceuticals 4552.T	Japan	$383M	-11%	+3%	-14%	2.9×	n/a	n/a
KYORIN Pharmaceutical 4569.T	Japan	$362M	-30%	-5%	2%	0.5×	10.5%	+4.2%
MapLight Therapeutics MPLT	United States	$385M	-75%	n/a	n/a	n/a	n/a	n/a
iX Biopharma 42C.SI	Singapore	$386M	+10%	-12%	-140%	70.7×	n/a	n/a
Lumosa Therapeutics 6535.TWO	Taiwan	$356M	-49%	-8%	-883%	324.5×	n/a	n/a
Tiansheng Pharmaceutical 002872.SZ	China	$392M	+15%	-1%	-13%	5.2×	23.2%	-15.7%
Heartseed 219A.T	Japan	$393M	+52%	+197%	9%	21.4×	50.0%	+73.2%
SanBio 4592.T	Japan	$393M	-58%	n/a	n/a	n/a	n/a	n/a
Zota Health Care ZOTA.NS	India	$395M	-6%	+69%	-16%	5.8×	n/a	n/a
Pharmicell 005690.KS	South Korea	$352M	-56%	+51%	32%	3.2×	-6.6%	+24.8%
Zhejiang East Asia Pharmaceutical 605177.SS	China	$348M	-3%	+3%	-17%	3.1×	n/a	n/a

Questions

Which companies are Unichem Laboratories's closest peers?: The cockpit's peer set: Chongqing Hifuture Information Technology (002168.SZ), Anhui Fengyuan Pharmaceutical (000153.SZ), Avalo Therapeutics (AVTX), Shukra Pharmaceuticals (SHUKRAPHAR.NS), Rezolute (RZLT), Guizhou Yibai Pharmaceutical (600594.SS), Kingchem (Liaoning) Life Science (301509.SZ), Hinova Pharmaceuticals (688302.SS).
Is Unichem Laboratories expensive compared with its peers?: On ev / sales it trades at 1.5× against a peer median of 5.2×, 3rd cheapest of 16 in its peer set.
How has Unichem Laboratories stock performed?: Over six months to 6 Nov 2026 the shares returned +27.9% against -21.9% for the median peer; over one year +5.8%.